Yourgene up on regulatory nod

AIM-listed molecular diagnostics specialist Yourgene Health (LON:YGEN) has seen its share price climb by 6.51% to 19.97p (as of 15:00 BST) after it received accreditation from the Care Quality Commission for its second facility in Manchester.

The company said that this allowed them greater flexibility to provide both public and private COVID testing in the city.